168 related articles for article (PubMed ID: 24918383)
1. Chemoimmunotherapy for chronic lymphocytic leukemia. Author reply.
Goede V; Fischer K; Hallek M
N Engl J Med; 2014 Jun; 370(24):2348-9. PubMed ID: 24918383
[No Abstract] [Full Text] [Related]
2. Chemoimmunotherapy for chronic lymphocytic leukemia.
Spehn J; Mühlbauer B
N Engl J Med; 2014 Jun; 370(24):2348. PubMed ID: 24918384
[No Abstract] [Full Text] [Related]
3. Movement toward optimization of CLL therapy.
Rai KR; Barrientos JC
N Engl J Med; 2014 Mar; 370(12):1160-2. PubMed ID: 24645950
[No Abstract] [Full Text] [Related]
4. Obinutuzumab: a novel anti-CD20 monoclonal antibody for previously untreated chronic lymphocytic leukemia.
Shah A
Ann Pharmacother; 2014 Oct; 48(10):1356-61. PubMed ID: 25037849
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with the type II anti-CD20 antibody obinutuzumab.
Klein C; Bacac M; Umana P; Fingerle-Rowson G
Expert Opin Investig Drugs; 2017 Oct; 26(10):1145-1162. PubMed ID: 28845710
[TBL] [Abstract][Full Text] [Related]
6. Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations.
Reda G; Orofino N; Cassin R; Sciumè M; Fattizzo B; Cortelezzi A
Expert Opin Drug Saf; 2016 Jun; 15(6):865-73. PubMed ID: 26967902
[TBL] [Abstract][Full Text] [Related]
7. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.
Goede V; Fischer K; Busch R; Engelke A; Eichhorst B; Wendtner CM; Chagorova T; de la Serna J; Dilhuydy MS; Illmer T; Opat S; Owen CJ; Samoylova O; Kreuzer KA; Stilgenbauer S; Döhner H; Langerak AW; Ritgen M; Kneba M; Asikanius E; Humphrey K; Wenger M; Hallek M
N Engl J Med; 2014 Mar; 370(12):1101-10. PubMed ID: 24401022
[TBL] [Abstract][Full Text] [Related]
8. Obinutuzumab for the treatment of chronic lymphocytic leukemia.
Rogers KA; Jones JA
Drugs Today (Barc); 2014 Jun; 50(6):407-19. PubMed ID: 24983589
[TBL] [Abstract][Full Text] [Related]
9. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
Brown JR
Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
[No Abstract] [Full Text] [Related]
10. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study.
Goede V; Fischer K; Engelke A; Schlag R; Lepretre S; Montero LF; Montillo M; Fegan C; Asikanius E; Humphrey K; Fingerle-Rowson G; Hallek M
Leukemia; 2015 Jul; 29(7):1602-4. PubMed ID: 25634683
[No Abstract] [Full Text] [Related]
11. Obinutuzumab Plus Chlorambucil in a Patient with Severe Myasthenia Gravis and Chronic Lymphocytic Leukemia.
Russell A; Yaraskavitch M; Fok D; Chhibber S; Street L; Korngut L
J Neuromuscul Dis; 2017; 4(3):251-257. PubMed ID: 28869483
[TBL] [Abstract][Full Text] [Related]
12. Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience.
Autore F; Fresa A; Innocenti I; Tomasso A; Morelli F; Corbingi A; Sorà F; Laurenti L
Hematol Oncol; 2019 Dec; 37(5):641-643. PubMed ID: 31604368
[No Abstract] [Full Text] [Related]
13. Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation.
Kakkar AK; Balakrishnan S
J Oncol Pharm Pract; 2015 Oct; 21(5):358-63. PubMed ID: 24827578
[TBL] [Abstract][Full Text] [Related]
14. Obinutuzumab (Gazyva) for chronic lymphocytic leukemia.
Med Lett Drugs Ther; 2014 Nov; 56(1455):e114-5. PubMed ID: 25538980
[No Abstract] [Full Text] [Related]
15. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.
Pejsa V; Lucijanic M; Jonjic Z; Prka Z; Vukorepa G
Ann Hematol; 2019 Jun; 98(6):1509-1510. PubMed ID: 30421169
[No Abstract] [Full Text] [Related]
16. A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Offner F; Robak T; Janssens A; Govind Babu K; Kloczko J; Grosicki S; Mayer J; Panagiotidis P; Schuh A; Pettitt A; Montillo M; Werner O; Vincent G; Khanna S; Hillmen P
Br J Haematol; 2020 Sep; 190(5):736-740. PubMed ID: 32236950
[TBL] [Abstract][Full Text] [Related]
17. Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia.
Seiter K; Mamorska-Dyga A
Clin Interv Aging; 2015; 10():951-61. PubMed ID: 26109852
[TBL] [Abstract][Full Text] [Related]
18. CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL.
Fakhri B; Andreadis C
Oncology (Williston Park); 2019 Nov; 33(11):. PubMed ID: 31769861
[No Abstract] [Full Text] [Related]
19. Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia.
Goede V; Eichhorst B; Fischer K; Wendtner CM; Hallek M
Leuk Lymphoma; 2015 Jun; 56(6):1585-92. PubMed ID: 25219593
[TBL] [Abstract][Full Text] [Related]
20. A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.
Ladyzynski P; Molik M; Foltynski P
Cancer Treat Rev; 2015 Feb; 41(2):77-93. PubMed ID: 25512118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
